Remotely Supervised Exercise for Adults With Cystic Fibrosis
- Conditions
- Cystic Fibrosis
- Interventions
- Other: Exercise
- Registration Number
- NCT05173194
- Lead Sponsor
- Universidad Europea de Madrid
- Brief Summary
Cystic fibrosis (CF) is a genetic disease characterized by abnormal chloride transport in epithelial tissues. Inflammation is a key component contributing to the main alterations induced by the disease. The increase in life expectancy comes with a higher prevalence of CF-related comorbidities, but also with new emerging complications directly related to aging. Physical fitness and exercise practice have been previously associated to survival and better quality of life in patients with cystic fibrosis. Thus, the aim of this study is to assess the effects of a remotely supervised resistance exercise program on lung function, muscle strength, body composition, quality of life and inflammatory markers in adult patients with cystic fibrosis.
- Detailed Description
This study aims to assess the effects of a remotely supervised resistance exercise program on lung function, muscle strength, body composition, quality of life and inflammatory markers in adult patients with cystic fibrosis.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 32
- Confirmed clinical and genetic diagnosis for cystic fibrosis;
- Age from 16 years.
- Musculoskeletal disorders that do not allow the performance of physical exercise;
- Pregnancy;
- Absence of registration of clinical required.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Telematic Exercise Exercise A remotely supervised resistance exercise program will be carried out for 8 weeks, with three weekly sessions lasting approximately 60 minutes each. Training will be performed in groups of four patients, according to their lung function/physical fitness. The first training session will be on site (University) for familiarization, planning and adjustment of the exercises, and the following sessions will be performed online. Each session is divided into: (i) Warm-up and joint mobility; (ii) main part: strength exercises for different muscle groups; and (iii) cool down: stretching and breathing exercises.
- Primary Outcome Measures
Name Time Method Change in plasmatic levels of Klotho Baseline and 8 weeks Change from baseline to 8 weeks
Change in peripheral muscle strength. Upper and lower limb muscle strength will be evaluated using the 5 maximum repetition test in specific strength machines. Handgrip strength will be measured with a dynamometer. Baseline and 8 weeks Change from baseline to 8 weeks
Change in body composition (muscle mass and skeletal mass index - kg/m2) measured through dual-energy x-ray absorptiometry (DEXA) Baseline and 8 weeks Change from baseline to 8 weeks
Change in plasmatic levels of interleukins (IL-8 and IL-10) Baseline and 8 weeks Change from baseline to 8 weeks
- Secondary Outcome Measures
Name Time Method Change in Pulmonary Function (Lung Function) Baseline and 8 weeks Change from baseline to 8 weeks
Change in quality of life evaluated using the Cystic Fibrosis Questionnaire (CFQ-R +14). Scores range from 0 to 100 with higher scores corresponding to better quality of life. Baseline and 8 weeks Change from baseline to 8 weeks
Change in inspiratory muscle strength (MIP) Baseline and 8 weeks Change from baseline to 8 weeks
Change in functional capacity (30 seconds sit-to-stand test) Baseline and 8 weeks Change from baseline to 8 weeks
Trial Locations
- Locations (1)
Hospital La Princesa
🇪🇸Madrid, Spain